Science & Medicine

Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?

ASCO Daily News by American Society of Clinical Oncology (ASCO)

Feb 5, 202614:53Science & Medicine

Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer, and its place among a growing body o...

About This Episode

Can Low-Dose Immunotherapy Expand Global Access to Cancer Care? is an episode from ASCO Daily News by American Society of Clinical Oncology (ASCO). Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-do...

Podcast

This episode belongs to ASCO Daily News.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Feb 5, 2026, 14:53 long, audio available.

Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?

About This Episode

Related Episodes